Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation
Submission of Results Presentation under Regulation 30(6) of the SEBI (LODR) Regulations, 201508-02-2023
08-02-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, this is to inform you that the Board of Directors of the Company has approved the appointment of Ms. Komal Gupta from the Chief Financial Officer (CFO) to the Chief Executive Officer (CEO) of the Company with effect from 08th February, 2023.08-02-2023
Windlas Biotech Ltd - 543329 - Outcome Of The Meeting Of The Board Of Directors Of Windlas Biotech Limited ('The Company') In Terms Of Regulation 30 And Regulation 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Outcome of the meeting of the Board of Directors of Windlas Biotech Limited ('the Company') in terms of Regulation 30 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.08-02-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 201806-02-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 201803-02-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 201801-02-2023
Windlas Biotech Ltd - 543329 - Submission Of Details Of Extinguishment Pursuant To Provisions Of Regulation 21 Read With Regulation 11 Of The SEBI (Buy-Back Of Securities) Regulations, 2018
this is to inform that, pursuant to the provisions of Regulation 21 read with Regulation 11 of the Buy-back Regulations, the Company has completed the extinguishment of 7,260 (Seven Thousand Two Hundred and Sixty) equity shares bought back under the Buy-back during the period from January 19, 2023 till January 25, 2023. In connection with the same, we are submitting herewith details of extinguishment along with the debit confirmation letter received from the Central Depository Services Limited and Certificate of Extinguishment for your records.01-02-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to the captioned subject and pursuant to Clause 15 of Schedule III, Part A, Para A read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the conference call to discuss financial performance of the Company for the quarter ended December 31, 2022 is scheduled to be held as per the details given below: Day Thursday Date February 09, 2023 Time 11:00 A.M. IST Invite Refer Invite appended below31-01-2023
Windlas Biotech Ltd - 543329 - Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Wednesday, The February 08, 2023
Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 ,inter alia, to consider and approve Notice is hereby given that pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, February 08, 2023, inter alia, to consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2022. Please be also advised that in accordance with Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015, the Trading Window of the Company is already closed from January 01, 2023, and it shall reopen on February 11, 2023.30-01-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 201830-01-2023